中/EN: 中文繁體 English

Investor Relations
IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
Corporate

Press Releases

2014

Please select

AUG
21

The United Laboratories International Holdings Limited Announces 2014 Interim Results, Profit Attributable to the Owners of the Company, Substantially Increased by 15 Times to Approximately HK$710 Million, Sustained Growth in Selling Price of Intermediate Products and Bulk Medicine, Satisfactory Sales Performance of Insulin Products

MAR
28

The United Laboratories International Holdings Limited Announces 2013 Annual Results, Turnover Increased to HK$7.65 Billion, Continued to Achieve Stable Business Growth, Outstanding Sales Performance of the Recombinant Human Insulin Products